Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2021-03-23 Audit Report / Informat…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Vivozon Healthcare' (주식회사 비보존 헬스케어) for the fiscal year 2020. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and notes to the financial statements. While it contains financial data, it is a formal audit report rather than a full 10-K annual report or a simple earnings release. Therefore, it is classified as an Audit Report. FY 2020
2021-03-23 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a 'Notice of General Meeting of Shareholders' (주주총회소집공고). It contains detailed financial statements (balance sheets, income statements, cash flow statements) as part of the management reference materials for the upcoming shareholder meeting. Since the primary purpose of the filing is to provide updated information for the Annual General Meeting (AGM) and it includes the specific agenda items and financial disclosures for that meeting, it is classified as AGM Information.
2021-03-22 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류). It details corrections made to financial statements (재무제표) following an audit. Since the primary purpose of the document is to provide information to shareholders regarding voting matters at a general meeting, and it is a formal regulatory filing for proxy solicitation, it falls under the Proxy Solicitation & Information Statement category.
2021-03-22 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Vivozon Healthcare) regarding a correction to a previously filed disclosure about a significant change in financial results (30% or more change in revenue or profit/loss). It details the specific line items that were corrected following the finalization of financial statements. This type of filing is a standard regulatory announcement in the Korean market (DART system) and falls under the 'Regulatory Filings' category as it is a specific corporate disclosure update that does not fit into the other specialized categories like Earnings Release or Annual Report. FY 2020
2021-03-22 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Vivozon Healthcare. It contains the meeting agenda, details on board activities, and financial statements (balance sheets) for the 19th fiscal year. While it contains financial data, it is primarily a proxy statement/notice sent to shareholders to inform them of the upcoming meeting and request their participation/votes. In the context of financial filings, this is classified as a Proxy Solicitation & Information Statement.
2021-03-17 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the meeting agenda, proxy solicitation details, and financial statements as reference material for shareholders. This falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.